Navigation Links
Syndax Pharmaceuticals' Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
Date:12/9/2010

ell Lung Cancer Patients With Differential Sensitivity To Histone Deacetylase Inhibitor (hdaci) / Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (egfr-tki) Treatment" was accepted as a late-breaker and will be given as an oral presentation at a scientific session at 2:15 p.m. on Friday, December 10, 2010.

For more Information regarding the presentation please visit http://www.thoracicsymposium.org/.

About Non-Small Cell Lung Cancer (NSCLC) Non-small cell lung cancer, a disease in which malignant cells form in the tissues of the lungs, is the most common type of lung cancer. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Each year there are more than 200,000 cases of newly diagnosed advanced NSCLC. About 60% of patients present with advanced NSCLC, meaning it has spread beyond the lung, when they are seen by a doctor. The five-year survival rate is less than 10 percent for patients with advanced NSCLC.

About Entinostat Entinostat is an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor with a long half-life that allows for weekly or every-other-week dosing. In addition to ENCORE 401, entinostat is being studied in numerous phase 2 clinical trials including a trial in advanced breast cancer patients in combination with aromatase inhibitors and in a Hodgkin's lymphoma trial as a single agent. Under a Cooperative Research and Development Agreement (CRADA) with the NCI, Entinostat also is being studied in multiple types of solid tumors and hematologic cancers.

Research has shown that HDACs are involved in the expression of various genes that regulate cell growth, differentiation and apoptosis. Such genes are frequently silenced in cancer cells through the over-expression of enzymes including HDACs. HDACs are therefore recognized as promising targets for cancer treatmen
'/>"/>

SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
3. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SHENZHEN, China , 2. Juli 2015 /PRNewswire/ ... Hochdurchsatz-Labor für DNA-Screening in Hongkong vom American ... BGI-Einrichtung in Hongkong ist das erste klinische ... ein CAP-Zertifkat erhält und somit ... Ergänzend zu den bestehenden US FDA - ...
(Date:7/2/2015)... , July 2, 2015  The Commission ... agreement with ASHP, an organization that represents pharmacists ... a provider of continuing education for recertification of ... track of geriatric programs for this purpose.  ASHP ... as authorized providers for the CCGP Professional Development ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION ... a new E-CUBE Series ultrasound system. Developed to enhance ... clinical areas, the E-CUBE 15 EX produces superb image ... clinical performance in women,s health, general imaging, and shared ... The latest in the renowned E-CUBE Series, the ...
Breaking Medicine Technology:BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical ... unaudited financial results for the three months ended September ... 30, 2009 , As of September 30, 2009, ... and an additional $50.9 million in investment securities, available-for-sale. ...
... Health Group, Inc., (EHG), a provider of enhanced connectivity, ... providers in the dental industry, today announced its full ... provide a single-source solution for EDI transactions between the ... Management Software is an intuitive, full-featured program designed to ...
Cached Medicine Technology:Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 9Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 10EDI Health Group Partners With Orthoease to Incorporate Claims Processing Into Company's Robust Practice Management Software 2EDI Health Group Partners With Orthoease to Incorporate Claims Processing Into Company's Robust Practice Management Software 3
(Date:7/2/2015)... ... 2015 , ... The American Association of Poison Control Centers ... Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with the Senate ... drug overdose – especially of heroin and opioid medication – by expanding the ...
(Date:7/2/2015)... ... 2015 , ... Many Fourth of July celebrations will include fireworks this summer, ... is sharing some tips to promote the proper use of fireworks. , According to ... room daily with fireworks-related injuries in the month surrounding the Fourth of July. Amica ...
(Date:7/2/2015)... ... 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was fully in ... write his first poem, and three years later he was publishing an entire book of ... with the world. "I have always believed that the best way to lift yourself up, ...
(Date:7/2/2015)... ... , ... As Americans celebrate the Fourth of July outdoors this weekend, local ... rise. July is UV Safety Month, and physicians at American Family Care and AFC ... checks. Experts say most skin cancers can be found early with regular skin exams. ...
(Date:7/2/2015)... ... 2015 , ... Global leader and compression innovator, SIGVARIS North America, ... , For style that’s quick on its feet, men will love this fun new ... men everywhere because a simple change in socks can dramatically help improve overall leg ...
Breaking Medicine News(10 mins):Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3
... The same filtered light that enables sunglasses to reduce ... signs of cervical cancer, reducing unnecessary biopsies and surgery. ... light which scatters in all directions, said Dr. Daron ... the Gynecologic Cancer Prevention Center at Georgia Health Sciences ...
... (BRONX, NY) Using advanced imaging techniques and cognitive tests, ... of Yeshiva University and Montefiore Medical Center , ... shown that repeatedly heading a soccer ball increases the risk ... the findings was presented today at the annual meeting of ...
... published today in the international journal Addiction demonstrates ... seem to affect the number of violent incidents. The findings ... to an increase of an average of 20 violent cases ... represents an increase in violence of approximately 16 percent. ...
... Orleans, LA Research led by Dr. Paul Harch, ... Center New Orleans, has found that treatment with hyperbaric ... and quality of life for veterans with traumatic brain ... online now in the Journal of Neurotrauma . ...
... Nov. 28 (HealthDay News) --,Women over 50 have more complications ... women do, a new study says. The higher rate ... changes in hormone levels, according to the researchers. They ... 1999 and 2009 and found that the post-surgery infection rate ...
... 28 (HealthDay News) -- The severity of a heart attack can ... study suggests. The analysis of data from more than 1,000 ... when people have a heart attack between 1 a.m. and 5 ... is 82 percent greater than during the time of day when ...
Cached Medicine News:Health News:Polarized filter may reduce unnecessary cervical biopsies and surgeries 2Health News:Frequent 'heading' in soccer can lead to brain injury and cognitive impairment 2Health News:Frequent 'heading' in soccer can lead to brain injury and cognitive impairment 3Health News:Norwegian study finds opening bars longer increases violence 2Health News:LSUHSC research shows Rx with hyperbaric oxygen improved TBI and PTSD in vets 2Health News:Older Women Have More Post-Surgical Breast Reduction Infections 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: